MedTrace Logo

Prophylactic Intravenous Tranexamic Acid on Perioperative Blood Loss in Pregnant Women Undergoing Cesarean Section

NCT07078942 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2025-07-28

No results posted yet for this study

Summary

The purpose of this study is to asses the effect of preoperative prophylactic intravenous tranexamic acid on perioperative blood loss in pregnant women undergoing cesarean section

Conditions

  • Pregnant Women Undergoing Cesarean Delivery

Interventions

DRUG

Tranexamic Acid

Tranexamic Acid 1 g intravenous preoperation

OTHER

Placebo

normal saline 20 ml intravenous preoperation

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Vorapong Phupong, M.D. · Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-20
Primary Completion
2026-07-31
Completion
2026-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07078942 on ClinicalTrials.gov